Lv11
70 积分 2024-08-12 加入
Factors related to ultrafiltration volume with icodextrin dialysate use in children
2小时前
待确认
Dosing, Treatment Pattern, and Safety of Finerenone Use in Routine Care: An Interim Analysis of the Prospective, Real-World, and Observational FINE-REAL Study
20天前
已关闭
Characteristics, Clinical Outcomes, and Safety of New Users of Finerenone with CKD and Type 2 Diabetes in Routine Clinical Practice in Japan: A FOUNTAIN Platform Analysis
26天前
已关闭
Effect of Fineronone on Heart Failure Outcomes in Type 2 Diabetes with Chronic Kidney Disease: An Early Indian Experience
1个月前
已完结
Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses from the FIGARO-DKD Trial
1个月前
已完结
Novel Genetic Variants Associated with Chronic Kidney Disease Progression
1个月前
已完结
Effect of finerenone on nephrotic syndrome in patients with diabetic kidney disease
1个月前
已完结
Effect of finerenone on diabetic kidney disease outcomes with estimated glomerular filtration rate below 25 mL/min/1.73 m2
1个月前
已完结
Effect of Fineronone on Heart Failure Outcomes in Type 2 Diabetes with Chronic Kidney Disease: An Early Indian Experience
1个月前
已完结
Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double‐blind, placebo‐controlled, Phase I trial
1个月前
已完结
皖公网安备34019202002308
